Rakovina Therapeutics Inc.
$56,803.00 CAD
≈ 9 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2021-2022
- Agreement period
- October 11, 2021 – June 30, 2022
- Reference
- nrc-cnrc:172-2021-2022-Q3-980818
Published purpose
Lead optimization of a novel class of small molecule anti-cancer agents through evaluation of their pharmacokinetic profiles and ability to penetrate the blood brain barrier.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions